Milnacipran Hydrochloride Kit
Product Images NDC 31722-880

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Milnacipran Hydrochloride (NDC 31722-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Milnacipran-hydrochloride-tablets100mg (Milnacipran Hydrochloride Tablets100mg)

Packaging label for Milnacipran Hydrochloride Tablets 100 mg, film-coated oral tablets. The label indicates 60 tablets per container. Manufactured for Camber Pharmaceuticals, Inc. and by Hetero Labs Limited, India. Includes storage instructions, pharmacist medication guide reminder, and a barcode.*

FDA Label Image

Milnacipranhydrochloridetablets125 (Milnacipran Hydrochloride Tablets125)

Milnacipran Hydrochloride Tablets 12.5 mg film-coated oral tablets are shown in a 60-count bottle label by Camber Pharmaceuticals, Inc. The label includes storage instructions and contact information. It also states the tablets contain 12.5 mg of milnacipran hydrochloride and includes the NDC 31722-846-60.*

FDA Label Image

Milnacipran-hydrochloride-tablets25 (Milnacipran Hydrochloride Tablets25)

Label for Milnacipran Hydrochloride Tablets 25 mg film-coated tablets, provided by Camber Pharmaceuticals, Inc. The label states the package contains 60 tablets and indicates prescription use only. The label includes storage instructions, pharmacist dispensing guidance, manufacturer details including Hetero Labs Limited, India, and a contact number and website for medication guides.*

FDA Label Image

Milnacipran-hydrochloride-tablets50 (Milnacipran Hydrochloride Tablets50)

Milnacipran Hydrochloride Tablets 50 mg film coated oral tablets packaging label by Camber Pharmaceuticals, Inc. The label includes dosage, storage instructions, quantity of 60 tablets, and manufacturer details for Hetero Labs Limited, India. It also displays the NDC code 31722-848-60 and a barcode.*

FDA Label Image

Milnacipran-hydrochloride-tabletscamberlogo (Milnacipran Hydrochloride Tabletscamberlogo)

FDA Label Image

Milnacipran-hydrochloride-tabletsfigure1 (Milnacipran Hydrochloride Tabletsfigure1)

A line graph depicting the percent of patients improved versus percent improvement in pain from baseline. It compares Placebo, Milnacipran Hydrochloride (MLN) 100 mg, and MLN 200 mg groups, showing trends of patient improvement across increasing pain improvement percentages.*

FDA Label Image

Milnacipran-hydrochloride-tabletsfigure2 (Milnacipran Hydrochloride Tabletsfigure2)

A line graph showing the percent of patients improved versus percent improvement in pain from baseline for placebo, Milnacipran Hydrochloride 100 mg, and Milnacipran Hydrochloride 200 mg. The graph has three lines indicating different treatments and compares the percentage of patients with various levels of pain improvement.*

FDA Label Image

Milnacipran-hydrochloride-tabletsformula (Milnacipran Hydrochloride Tabletsformula)

Chemical structure diagram of milnacipran hydrochloride, showing the arrangement of atoms and bonds including an amino group, cyclopropane ring, phenyl group, and hydrochloride salt.*

FDA Label Image

Milnacipran-hydrochloride-tablets100mg (Milnacipran Hydrochloride Tabletstitrationpack)

Milnacipran Hydrochloride Tablets 4-week Titration Pack by Camber Pharmaceuticals, Inc. The pack includes film-coated tablets with strengths 12.5 mg, 25 mg, and 50 mg in a calendar-format blister card designed for titration over 28 days. The packaging features day-by-day dosing instructions with morning and evening doses clearly labeled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.